Overview
Hanchun Chen practices practicing medicine in Changsha, China.
Their clinical expertise encompasses Retinopathy Pigmentary Mental Retardation, X-Linked Retinitis Pigmentosa (XLRP), Trophoblastic Tumor Placental Site, and Severe Acute Respiratory Syndrome (SARS).
They are actively involved in clinical research, co-authoring 31 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hanchun P. Chen
Is Hanchun P. Chen a top-rated expert for Retinopathy Pigmentary Mental Retardation?
MediFind is an objective health platform that identifies experts based on real-world data. Hanchun P. Chen is classified as an Experienced expert for Retinopathy Pigmentary Mental Retardation, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hanchun P. Chen participate in research or clinical trials?
Yes. Hanchun P. Chen has published 31 articles and abstracts on conditions like Retinopathy Pigmentary Mental Retardation. You can view a list of Hanchun P. Chen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerChen isExperienced. Learn about Breast Cancer.
- COVID-19Chen isExperienced. Learn about COVID-19.
- Retinopathy Pigmentary Mental Retardation
- Severe Acute Respiratory Syndrome (SARS)
- Trophoblastic Tumor Placental Site
- X-Linked Retinitis Pigmentosa (XLRP)